The patient was a 66-year-old man who had advanced gastric cancer with metastasis to liver and lymph nodes. He received daily oral administration of 100 mg of TS-1 for 28 days followed by 14 days rest as one treatment course. After 2 coures, regression of the primary lesion and reduction in size of the liver and lymph metastases were observed.
|ジャーナル||Gan to kagaku ryoho. Cancer & chemotherapy|
|出版ステータス||出版済み - 1 1 2005|
All Science Journal Classification (ASJC) codes
- Cancer Research